In addition to migrastatin, another investigation in colorectal cancer cells showed an antimigratory and anti-invasive effect of imipramine (anti-depressant) by inhibiting FSCN1 activity [75], thus introducing a novel molecular targeted treatment in FSCN1-induced tumors. This evidence concerns the gene FSCN1 and colorectal cancer.